BIOLASE, Inc.
BIOL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,632 | -$28,634 | -$16,158 | -$16,829 |
| Dep. & Amort. | $2,798 | $497 | $400 | $499 |
| Deferred Tax | $0 | $0 | -$3,613 | -$2,085 |
| Stock-Based Comp. | $1,232 | $2,303 | $1,662 | $3,370 |
| Change in WC | $1,025 | -$5,070 | $5 | $1,754 |
| Other Non-Cash | $1,486 | $4,143 | $994 | $496 |
| Operating Cash Flow | -$14,091 | -$26,761 | -$16,710 | -$12,795 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,311 | -$3,727 | -$707 | -$96 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $182 | -$3,727 | $0 | $0 |
| Investing Cash Flow | -$1,129 | -$3,727 | -$707 | -$96 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$165 | -$1,000 | $0 | $2,440 |
| Stock Issued | $9,553 | $5,602 | $14,420 | $6,912 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,046 | $1 | $15,534 | $14,997 |
| Financing Cash Flow | $17,434 | $4,603 | $29,954 | $24,349 |
| Forex Effect | $171 | -$109 | -$238 | $317 |
| Net Chg. in Cash | $2,385 | -$25,994 | $12,299 | $11,775 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,181 | $30,175 | $17,876 | $6,101 |
| End Cash | $6,566 | $4,181 | $30,175 | $17,876 |
| Free Cash Flow | -$15,402 | -$30,488 | -$17,417 | -$12,891 |